Statistics for Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021
Total visits
| views | |
|---|---|
| Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021 | 39 |
Total visits per month
| views | |
|---|---|
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 1 |
File Visits
| views | |
|---|---|
| eurosurv-26-29_4.pdf | 41 |
Top country views
| views | |
|---|---|
| United States | 16 |
| Portugal | 14 |
| Israel | 3 |
| China | 2 |
| Canada | 1 |
| Switzerland | 1 |
| Germany | 1 |
| United Kingdom | 1 |